Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:33447243

Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment.

Irmela Mantel · Angelica Borgo · Jacopo Guidotti · Edwige Forestier · Olga Kirsch · Yasmine Derradji · Patrice Waridel · Frédéric Burdet · Florence Mehl · Claude Schweizer · Raphaël Roduit

Frontiers in pharmacology · 2020 doi:10.3389/fphar.2020.594087

Paper

complete

Experiment

complete

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:33447243
kind
science-record
content_hash
sha256:6692be832d929608d859d6e75735d732c004ce2208f8c38935bf6f28ef2a1abc
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:41:22Z
updated_at
2026-11-01T21:24:31Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment.
doi
10.3389/fphar.2020.594087
pmid
33447243
authors array · 11 items
[0]
Irmela Mantel
[1]
Angelica Borgo
[2]
Jacopo Guidotti
[3]
Edwige Forestier
[4]
Olga Kirsch
[5]
Yasmine Derradji
[6]
Patrice Waridel
[7]
Frédéric Burdet
[8]
Florence Mehl
[9]
Claude Schweizer
[10]
Raphaël Roduit
journal
Frontiers in pharmacology
year
2020
abstract
The standard treatment for neovascular age-related macular degeneration (nAMD) consists of intravitreal anti-vascular endothelial growth factors (VEGF). However, for some patients, even maximal anti-VEGF treatment does not entirely suppress exudative activity. The goal of this study was to identify molecular biomarkers in nAMD with incomplete response to anti-VEGF treatment. Aqueous humor (AH) samples were collected from three groups of patients: 17 patients with nAMD responding incompletely to anti-VEGF (18 eyes), 17 patients affected by nAMD with normal treatment response (21 eyes), and 16 control patients without any retinopathy (16 eyes). Proteomic and multiplex analyses were performed on these samples. Proteomic analyses showed that nAMD patients with incomplete anti-VEGF response displayed an increased inflammatory response, complement activation, cytolysis, protein-lipid complex, and vasculature development pathways. Multiplex analyses revealed a significant increase of soluble vascular cell adhesion molecule-1 (sVCAM-1) [ p = 0.001], interleukin-6 (IL-6) [ p = 0.009], bioactive interleukin-12 (IL-12p40) [ p = 0.03], plasminogen activator inhibitor type 1 (PAI-1) [ p = 0.004], and hepatocyte growth factor (HGF) [ p = 0.004] levels in incomplete responders in comparison to normal responders. Interestingly, the same biomarkers showed a high intercorrelation with r2 values between 0.58 and 0.94. In addition, we confirmed by AlphaLISA the increase of sVCAM-1 [ p < 0.0001] and IL-6 [ p = 0.043] in the incomplete responder group. Incomplete responders in nAMD are associated with activated angiogenic and inflammatory pathways. The residual exudative activity of nAMD despite maximal anti-VEGF treatment may be related to both angiogenic and inflammatory responses requiring specific adjuvant therapy. Data are available via ProteomeXchange with identifier PXD02247.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
For analysis of the proteomics results, linear models (R function lm) adjusted for batches were used to identify differentially expressed proteins (p < 0.1) to compare group N and group R and to compare groups C/N and group R.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:33447243
locator
sections[11] "Bio-Informatic Analyses" paragraph 2
quote
For analysis of the proteomics results, linear models (R function lm) adjusted for batches were used to identify differentially expressed proteins (p < 0.1) to compare group N and group R and to compare groups C/N and group R.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD022471.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:33447243
locator
sections[20] "Data Availability Statement" paragraph 2
quote
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD022471.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:33447243
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD022471
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD022471
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 6 items
[0] object · 15 fields
id
source:pmid:33447243
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.3389/fphar.2020.594087
sha256
sha256:7f3a2d31011392e61dd1ae22fe61a517e00f57a4fd14f8a83937ec672ae2305f
bytes
57358
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.3389/fphar.2020.594087
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC7802772
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:PXD022471
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD022471
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
PXD022471
version
null
note
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD022471.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD022471.
access_statement_kind
data_availability_statement
sample_accessions array · 0 items
sample_count
null
group_sizes
null
group_sizes_basis
null
platform
null
taxon
null
title
Molecular biomarkers of neovascular age-related macular degeneration with incomplete response to anti-vascular endothelial growth factor treatment
resolution_checked_at
2026-10-31T18:35:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 16 fields
id
asset:table:pmid:33447243:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:4c72cb3d2ee6e9e926bc3ef335e5dfa9eb0eba95c8efbbdc9fe98a6203823d3a
bytes
2618
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[17]/table-wrap[1]#T2
version
null
note
Multiplex analysis of AH from nAMD patients with normal response (N), incomplete response (R) patients, and controls (C).
structure object · 5 fields
pmcid
PMC7802772
section_index
8
section_title
Multiplex Analysis
row_count
25
column_count
7
table object · 8 fields
label
TABLE 2
caption
Multiplex analysis of AH from nAMD patients with normal response (N), incomplete response (R) patients, and controls (C).
rows array · 25 items
[0] array · 5 items
[0]
[1]
Control C (n)
[2]
nAMD N (n)
[3]
rAMD R (n)
[4]
p values
[1] array · 3 items
[0]
C vs. N
[1]
C vs. R
[2]
R vs. N
[2] array · 7 items
[0]
VEGFR-1
[1]
100 ± 15.58 (9)
[2]
4,569 ± 1,228 (13)
[3]
4,738 ± 1,216 (12)
[4]
*0.024
[5]
*0.024
[6]
0.910
[3] array · 7 items
[0]
VEGFR-2
[1]
100 ± 5.85 (9)
[2]
172.1 ± 18.46 (13)
[3]
220.8 ± 28.66 (12)
[4]
0.055
[5]
*0.002
[6]
0.110
[4] array · 7 items
[0]
VEGF-A
[1]
100 ± 9.53 (14)
[2]
714 ± 142.8 (19)
[3]
712.4 ± 125.6 (18)
[4]
**0.003
[5]
**0.003
[6]
0.992
[5] array · 7 items
[0]
EGF
[1]
100 ± 2.14 (10)
[2]
105 ± 3.26 (10)
[3]
110.5 ± 1.71 (10)
[4]
0.242
[5]
*0.016
[6]
0.242
[6] array · 7 items
[0]
Eotaxin
[1]
100 ± 12.57 (13)
[2]
165 ± 23.5 (19)
[3]
238.8 ± 41.1 (18)
[4]
0.154
[5]
*0.011
[6]
0.151
[7] array · 7 items
[0]
HGF
[1]
100 ± 10.03 (14)
[2]
129.4 ± 10.82 (19)
[3]
232 ± 35.43 (18)
[4]
0.388
[5]
**0.001
[6]
**0.004
[8] array · 7 items
[0]
IL-12p40
[1]
100 ± 7.40 (14)
[2]
155.9 ± 14.15 (19)
[3]
210 ± 20.47 (18)
[4]
*0.031
[5]
#0.0001
[6]
*0.031
[9] array · 7 items
[0]
sVCAM-1
[1]
100 ± 8.93 (14)
[2]
122.8 ± 12.63 (19)
[3]
242.7 ± 35.69 (18)
[4]
0.511
[5]
#0.0005
[6]
**0.001
[10] array · 7 items
[0]
IL-6
[1]
100 ± 25.70 (6)
[2]
86.12 ± 64.25 (7)
[3]
10,546 ± 7,320 (10)
[4]
*0.042
[5]
0.11
[6]
**0.009
[11] array · 7 items
[0]
IP-10
[1]
100 ± 16.91 (14)
[2]
235.5 ± 42.06 (19)
[3]
280.2 ± 62.2 (18)
[4]
0.107
[5]
*0.038
[6]
0.490
[12] array · 7 items
[0]
MCP-1
[1]
100 ± 6.46 (14)
[2]
137.8 ± 11.16 (19)
[3]
154.3 ± 11.35 (18)
[4]
*0.032
[5]
**0.002
[6]
0.253
[13] array · 7 items
[0]
MMP-9
[1]
100 ± 18.31 (13)
[2]
233.3 ± 42.79 (19)
[3]
325.4 ± 64.23 (18)
[4]
0.144
[5]
*0.011
[6]
0.174
[14] array · 7 items
[0]
Adiponectin
[1]
100 ± 33.65 (4)
[2]
131.7 ± 32.36 (9)
[3]
173.2 ± 60.66 (8)
[4]
0.762
[5]
0.741
[6]
0.762
[15] array · 7 items
[0]
Eotaxin-3
[1]
100 ± 18.98 (5)
[2]
145.9 ± 27.1 (9)
[3]
120.3 ± 19.7 (10)
[4]
0.781
[5]
0.857
[6]
0.781
[16] array · 7 items
[0]
Ghrelin
[1]
100 ± 5.83 (4)
[2]
105.3 ± 5.74 (9)
[3]
103 ± 8.74 (8)
[4]
0.960
[5]
0.960
[6]
0.960
[17] array · 7 items
[0]
IL-3
[1]
100 ± 25.06 (5)
[2]
122.7 ± 36.17 (4)
[3]
110.5 ± 23.78 (5)
[4]
0.946
[5]
0.946
[6]
0.928
[18] array · 7 items
[0]
IL-7
[1]
100 ± 18.25 (8)
[2]
290.5 ± 44.59 (12)
[3]
360.1 ± 40.22 (11)
[4]
**0.006
[5]
#0.0005
[6]
0.203
[19] array · 7 items
[0]
MIF
[1]
100 ± 17.19 (4)
[2]
138.9 ± 20.84 (9)
[3]
133.5 ± 20.95 (8)
[4]
0.619
[5]
0.619
[6]
0.848
[20] array · 7 items
[0]
NGAL
[1]
100 ± 19.1 (9)
[2]
120.1 ± 10.53 (13)
[3]
135.4 ± 13.54 (12)
[4]
0.451
[5]
0.187
[6]
0.451
[21] array · 7 items
[0]
PaI-1
[1]
100 ± 8.5 (12)
[2]
179.9 ± 18.39 (13)
[3]
425.7 ± 89.64 (13)
[4]
0.304
[5]
#0.0005
[6]
**0.005
[22] array · 7 items
[0]
Gro-alpha-KC
[1]
100 ± 8.27 (14)
[2]
94.71 ± 5.60 (19)
[3]
162.7 ± 42.79 (17)
[4]
0.887
[5]
0.199
[6]
0.1669
[23] array · 7 items
[0]
IL-1RA
[1]
100 ± 32.02 (12)
[2]
70.77 ± 14.78 (16)
[3]
149 ± 61.91 (14)
[4]
0.652
[5]
0.652
[6]
0.4121
[24] array · 7 items
[0]
IL-13
[1]
100 ± 0.90 (10)
[2]
96.14 ± 3.46 (10)
[3]
97.66 ± 2.16 (10)
[4]
0.608
[5]
0.749
[6]
0.749
locator
section[17]/table-wrap[1]#T2
[3] object · 16 fields
id
asset:table:pmid:33447243:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:9433448ec5580580b89013d72a94685d735ef3a7ba74f99dc7c6d5127b033258
bytes
1735
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[13]/table-wrap[1]#T1
version
null
note
Demographic, phenotypic and treatment characteristics of each group based on the type of molecular analysis.
structure object · 5 fields
pmcid
PMC7802772
section_index
13
section_title
Clinical Characteristics
row_count
25
column_count
4
table object · 8 fields
label
TABLE 1
caption
Demographic, phenotypic and treatment characteristics of each group based on the type of molecular analysis.
rows array · 25 items
[0] array · 4 items
[0]
[1]
rAMD (R)
[2]
nAMD (N)
[3]
Control (C)
[1] array · 4 items
[0]
N patients
[1]
17
[2]
17
[3]
16
[2] array · 4 items
[0]
Mean age (SD)
[1]
81.6 (±6.5)
[2]
81.6 (±5.9)
[3]
70.44 ± 2.47
[3] array · 4 items
[0]
Females (%)
[1]
13 (76.5%)
[2]
13 (76.5%)
[3]
8/8
[4] array · 4 items
[0]
N eyes
[1]
18
[2]
19
[3]
16
[5] array · 4 items
[0]
Right eyes/left eyes
[1]
14/4
[2]
7/13
[3]
10/6
[6] array · 4 items
[0]
Neovascularization type: 1/2/3
[1]
15/2/1
[2]
16/3/1
[3]
—
[7] array · 4 items
[0]
Presence of reticular pseudodrusen (%)
[1]
5 (28%)
[2]
7 (35%)
[3]
—
[8] array · 4 items
[0]
Presence of fibrosis (%)
[1]
3 (17%)
[2]
4 (20%)
[3]
—
[9] array · 4 items
[0]
Presence of cRORA
[1]
4 (22%)
[2]
10 (50%)
[3]
—
[10] array · 4 items
[0]
Presence of iRORA
[1]
6 (33%)
[2]
14 (70%)
[3]
—
[11] array · 4 items
[0]
Recurrences including IRF (%)
[1]
9 (50%)
[2]
17 (85%)
[3]
—
[12] array · 4 items
[0]
Recurrences including SRF (%)
[1]
12 (67%)
[2]
8 (40%)
[3]
—
[13] array · 4 items
[0]
Mean CRT in micrometers (SD)
[1]
323 (±83)
[2]
286 (±76)
[3]
—
[14] array · 4 items
[0]
Mean subfoveal choroidal thickness in micrometers (SD)
[1]
150 (±121)
[2]
166 (±64)
[3]
—
[15] array · 4 items
[0]
Treatment duration in months ± SD
[1]
69.7 ± 35.1
[2]
55.4 ± 36.2
[3]
—
[16] array · 4 items
[0]
Number of injections received ± SD
[1]
59.6 ± 29.9
[2]
36.4 ± 26.7
[3]
—
[17] array · 4 items
[0]
Weeks from preceding injection ± SEM
[1]
5.89 ± 0.94
[2]
3.97 ± 0.29
[3]
—
[18] array · 4 items
[0]
Anti-VEGF agent used (ranib./Aflib.)
[1]
8/10
[2]
8/12
[3]
—
[19] array · 4 items
[0]
Number of switches performed
[1]
[2]
[3]
[20] array · 4 items
[0]
0
[1]
3
[2]
13
[3]
—
[21] array · 4 items
[0]
1
[1]
9
[2]
7
[3]
—
[22] array · 4 items
[0]
2
[1]
6
[2]
0
[3]
—
[23] array · 4 items
[0]
Mean visual acuity at treatment initiation in ETDRS letters ± SD
[1]
61.7 ± 12.5
[2]
63.1 ± 16.1
[3]
—
[24] array · 4 items
[0]
Mean visual acuity change from baseline in ETDRS letters ± SD
[1]
7.9 ± 12.5
[2]
Before cataract surgery −9.4 ± 12.9 after cataract surgery 12.8 ± 11.8
[3]
—
locator
section[13]/table-wrap[1]#T1
[4] object · 16 fields
id
asset:table:pmid:33447243:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:4c72cb3d2ee6e9e926bc3ef335e5dfa9eb0eba95c8efbbdc9fe98a6203823d3a
bytes
2618
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[17]/table-wrap[1]#T2
version
null
note
Multiplex analysis of AH from nAMD patients with normal response (N), incomplete response (R) patients, and controls (C).
structure object · 5 fields
pmcid
PMC7802772
section_index
17
section_title
Multiplex Analysis
row_count
25
column_count
7
table object · 8 fields
label
TABLE 2
caption
Multiplex analysis of AH from nAMD patients with normal response (N), incomplete response (R) patients, and controls (C).
rows array · 25 items
[0] array · 5 items
[0]
[1]
Control C (n)
[2]
nAMD N (n)
[3]
rAMD R (n)
[4]
p values
[1] array · 3 items
[0]
C vs. N
[1]
C vs. R
[2]
R vs. N
[2] array · 7 items
[0]
VEGFR-1
[1]
100 ± 15.58 (9)
[2]
4,569 ± 1,228 (13)
[3]
4,738 ± 1,216 (12)
[4]
*0.024
[5]
*0.024
[6]
0.910
[3] array · 7 items
[0]
VEGFR-2
[1]
100 ± 5.85 (9)
[2]
172.1 ± 18.46 (13)
[3]
220.8 ± 28.66 (12)
[4]
0.055
[5]
*0.002
[6]
0.110
[4] array · 7 items
[0]
VEGF-A
[1]
100 ± 9.53 (14)
[2]
714 ± 142.8 (19)
[3]
712.4 ± 125.6 (18)
[4]
**0.003
[5]
**0.003
[6]
0.992
[5] array · 7 items
[0]
EGF
[1]
100 ± 2.14 (10)
[2]
105 ± 3.26 (10)
[3]
110.5 ± 1.71 (10)
[4]
0.242
[5]
*0.016
[6]
0.242
[6] array · 7 items
[0]
Eotaxin
[1]
100 ± 12.57 (13)
[2]
165 ± 23.5 (19)
[3]
238.8 ± 41.1 (18)
[4]
0.154
[5]
*0.011
[6]
0.151
[7] array · 7 items
[0]
HGF
[1]
100 ± 10.03 (14)
[2]
129.4 ± 10.82 (19)
[3]
232 ± 35.43 (18)
[4]
0.388
[5]
**0.001
[6]
**0.004
[8] array · 7 items
[0]
IL-12p40
[1]
100 ± 7.40 (14)
[2]
155.9 ± 14.15 (19)
[3]
210 ± 20.47 (18)
[4]
*0.031
[5]
#0.0001
[6]
*0.031
[9] array · 7 items
[0]
sVCAM-1
[1]
100 ± 8.93 (14)
[2]
122.8 ± 12.63 (19)
[3]
242.7 ± 35.69 (18)
[4]
0.511
[5]
#0.0005
[6]
**0.001
[10] array · 7 items
[0]
IL-6
[1]
100 ± 25.70 (6)
[2]
86.12 ± 64.25 (7)
[3]
10,546 ± 7,320 (10)
[4]
*0.042
[5]
0.11
[6]
**0.009
[11] array · 7 items
[0]
IP-10
[1]
100 ± 16.91 (14)
[2]
235.5 ± 42.06 (19)
[3]
280.2 ± 62.2 (18)
[4]
0.107
[5]
*0.038
[6]
0.490
[12] array · 7 items
[0]
MCP-1
[1]
100 ± 6.46 (14)
[2]
137.8 ± 11.16 (19)
[3]
154.3 ± 11.35 (18)
[4]
*0.032
[5]
**0.002
[6]
0.253
[13] array · 7 items
[0]
MMP-9
[1]
100 ± 18.31 (13)
[2]
233.3 ± 42.79 (19)
[3]
325.4 ± 64.23 (18)
[4]
0.144
[5]
*0.011
[6]
0.174
[14] array · 7 items
[0]
Adiponectin
[1]
100 ± 33.65 (4)
[2]
131.7 ± 32.36 (9)
[3]
173.2 ± 60.66 (8)
[4]
0.762
[5]
0.741
[6]
0.762
[15] array · 7 items
[0]
Eotaxin-3
[1]
100 ± 18.98 (5)
[2]
145.9 ± 27.1 (9)
[3]
120.3 ± 19.7 (10)
[4]
0.781
[5]
0.857
[6]
0.781
[16] array · 7 items
[0]
Ghrelin
[1]
100 ± 5.83 (4)
[2]
105.3 ± 5.74 (9)
[3]
103 ± 8.74 (8)
[4]
0.960
[5]
0.960
[6]
0.960
[17] array · 7 items
[0]
IL-3
[1]
100 ± 25.06 (5)
[2]
122.7 ± 36.17 (4)
[3]
110.5 ± 23.78 (5)
[4]
0.946
[5]
0.946
[6]
0.928
[18] array · 7 items
[0]
IL-7
[1]
100 ± 18.25 (8)
[2]
290.5 ± 44.59 (12)
[3]
360.1 ± 40.22 (11)
[4]
**0.006
[5]
#0.0005
[6]
0.203
[19] array · 7 items
[0]
MIF
[1]
100 ± 17.19 (4)
[2]
138.9 ± 20.84 (9)
[3]
133.5 ± 20.95 (8)
[4]
0.619
[5]
0.619
[6]
0.848
[20] array · 7 items
[0]
NGAL
[1]
100 ± 19.1 (9)
[2]
120.1 ± 10.53 (13)
[3]
135.4 ± 13.54 (12)
[4]
0.451
[5]
0.187
[6]
0.451
[21] array · 7 items
[0]
PaI-1
[1]
100 ± 8.5 (12)
[2]
179.9 ± 18.39 (13)
[3]
425.7 ± 89.64 (13)
[4]
0.304
[5]
#0.0005
[6]
**0.005
[22] array · 7 items
[0]
Gro-alpha-KC
[1]
100 ± 8.27 (14)
[2]
94.71 ± 5.60 (19)
[3]
162.7 ± 42.79 (17)
[4]
0.887
[5]
0.199
[6]
0.1669
[23] array · 7 items
[0]
IL-1RA
[1]
100 ± 32.02 (12)
[2]
70.77 ± 14.78 (16)
[3]
149 ± 61.91 (14)
[4]
0.652
[5]
0.652
[6]
0.4121
[24] array · 7 items
[0]
IL-13
[1]
100 ± 0.90 (10)
[2]
96.14 ± 3.46 (10)
[3]
97.66 ± 2.16 (10)
[4]
0.608
[5]
0.749
[6]
0.749
locator
section[17]/table-wrap[1]#T2
[5] object · 16 fields
id
asset:table:pmid:33447243:4
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:60d7eb0ee8ab4d0c44bf2396ba1dbe52b111c6c2797865d8207d7d31d2956d09
bytes
1783
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[18]/table-wrap[1]#T3
version
null
note
Clinical-Molecular Association Analysis: The five relevant molecules, associated with incomplete anti-VEGF response, were explored for potential associations with clinical parameters, in all neovascular age-related macular degeneration (nAMD) eyes included. Correlation analysis was performed for continuous variable, and Anova test for categorical variables.
structure object · 5 fields
pmcid
PMC7802772
section_index
18
section_title
Exploratory Clinical-Molecular Correlation
row_count
16
column_count
13
table object · 8 fields
label
TABLE 3
caption
Clinical-Molecular Association Analysis: The five relevant molecules, associated with incomplete anti-VEGF response, were explored for potential associations with clinical parameters, in all neovascular age-related macular degeneration (nAMD) eyes included. Correlation analysis was performed for continuous variable, and Anova test for categorical variables.
rows array · 16 items
[0] array · 7 items
[0]
[1]
sVCAM-1
[2]
IL-12p40
[3]
IL-6
[4]
PAI-1
[5]
HGF
[6]
VEGF-A
[1] array · 13 items
[0]
Continuous variables
[1]
r2
[2]
p
[3]
r2
[4]
p
[5]
r2
[6]
p
[7]
r2
[8]
p
[9]
r2
[10]
p
[11]
r2
[12]
p
[2] array · 13 items
[0]
Age
[1]
0.20
[2]
0.22
[3]
0.32
[4]
0.05
[5]
0.17
[6]
0.29
[7]
0.24
[8]
0.13
[9]
0.38
[10]
0.01
[11]
0.07
[12]
0.67
[3] array · 13 items
[0]
N anti-VEGF injections
[1]
0.26
[2]
0.10
[3]
0.30
[4]
0.06
[5]
0.26
[6]
0.11
[7]
0.13
[8]
0.42
[9]
0.26
[10]
0.10
[11]
0.13
[12]
0.42
[4] array · 13 items
[0]
N months of treatment
[1]
0.14
[2]
0.40
[3]
0.21
[4]
0.19
[5]
0.25
[6]
0.10
[7]
0.08
[8]
0.60
[9]
0.15
[10]
0.35
[11]
0.09
[12]
0.60
[5] array · 13 items
[0]
VA change from baseline
[1]
0.18
[2]
0.25
[3]
0.01
[4]
0.93
[5]
−0.35
[6]
0.03
[7]
0.16
[8]
0.32
[9]
0.18
[10]
0.27
[11]
−0.11
[12]
0.47
[6] array · 13 items
[0]
Central retinal thickness
[1]
0.19
[2]
0.24
[3]
0.29
[4]
0.07
[5]
0.04
[6]
0.80
[7]
0.26
[8]
0.12
[9]
0.18
[10]
0.26
[11]
0.04
[12]
0.82
[7] array · 13 items
[0]
Subfoveal choroidal thickness
[1]
−0.40
[2]
0.01
[3]
−0.46
[4]
0.003
[5]
−0.27
[6]
0.10
[7]
−0.26
[8]
0.10
[9]
−0.44
[10]
0.005
[11]
−0.14
[12]
0.38
[8] array · 7 items
[0]
Categorical variables
[1]
p
[2]
p
[3]
p
[4]
p
[5]
p
[6]
p
[9] array · 7 items
[0]
Reticular pseudodrusen
[1]
0.38
[2]
0.69
[3]
0.36
[4]
0.56
[5]
0.86
[6]
0.58
[10] array · 7 items
[0]
Intraretinal fluid
[1]
0.74
[2]
0.87
[3]
0.22
[4]
0.41
[5]
0.8
[6]
0.55
[11] array · 7 items
[0]
Subretinal fluid
[1]
0.73
[2]
0.4
[3]
0.42
[4]
0.99
[5]
0.93
[6]
0.69
[12] array · 7 items
[0]
cRORA
[1]
0.83
[2]
0.7
[3]
0.36
[4]
0.36
[5]
0.7
[6]
0.51
[13] array · 7 items
[0]
iRORA
[1]
0.97
[2]
0.61
[3]
0.42
[4]
0.89
[5]
0.71
[6]
0.65
[14] array · 7 items
[0]
CNV type
[1]
0.1
[2]
0.62
[3]
0.83
[4]
0.005
[5]
0.36
[6]
0.38
[15] array · 7 items
[0]
Fibrosis
[1]
0.95
[2]
0.92
[3]
0.66
[4]
0.5
[5]
0.99
[6]
0.5
locator
section[18]/table-wrap[1]#T3
gaps array · 2 items
[0]
asset:data:geo:PXD022471 not downloaded
[1]
asset:data:geo:PXD022471 licence not read
analysis object · 4 fields
state
partial
methods array · 1 item
[0] object · 10 fields
id
method-1
family
null
specific
null
label
Linear models adjusted for batches
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
For analysis of the proteomics results, linear models (R function lm) adjusted for batches were used to identify differentially expressed proteins (p < 0.1) to compare group N and group R and to compare groups C/N and group R.
targets array · 0 items
gaps array · 1 item
[0]
method.reader_named_unmapped
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocking_axis
method
blocked_on
method:not_determinable
axes object · 3 fields
method object · 5 fields
tier
R4
expressible
false
required_operations array · 0 items
missing_operations array · 0 items
basis
The reader quoted the method the paper names (Linear models adjusted for batches), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
PXD022471
resolved_accessions array · 1 item
[0]
PXD022471
statements array · 1 item
[0]
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD022471.
basis
The paper names PXD022471 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 6 items
[0]
source:pmid:33447243
[1]
data:geo:PXD022471
[2]
asset:table:pmid:33447243:1
[3]
asset:table:pmid:33447243:2
[4]
asset:table:pmid:33447243:3
[5]
asset:table:pmid:33447243:4
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:PXD022471
gaps array · 1 item
[0]
method:not_determinable
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:26:11Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
3
usage object · 3 fields
prompt_tokens
44123
completion_tokens
1449
cached_tokens
14856
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:33447243
type
paper
label
pmid:33447243
[1] object · 3 fields
id
source:pmid:33447243
type
manuscript
label
PMID 33447243 full text
[2] object · 3 fields
id
data:geo:PXD022471
type
dataset
label
GEO PXD022471
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:33447243
type
paper
label
pmid:33447243
[1] object · 3 fields
id
source:pmid:33447243
type
manuscript
label
PMID 33447243 full text
[2] object · 3 fields
id
data:geo:PXD022471
type
dataset
label
GEO PXD022471
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-33447243
type
extraction
used array · 1 item
[0]
source:pmid:33447243
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-PXD022471
type
accession_resolution
used array · 1 item
[0]
data:geo:PXD022471
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:33447243
parent_hash
sha256:db3b0101ffe8f094980180f8efab593032625d771e8696f8e225ea82fc6a00ae
fork_of
null
gaps array · 7 items
[0]
asset:data:geo:PXD022471 licence not read
[1]
asset:data:geo:PXD022471 not downloaded
[2]
execution.not_run
[3]
method.reader_named_unmapped
[4]
review.human_critique
[5]
review.independent_reader
[6]
review.machine_critique
Complete file
{"sci_version": "1.0", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:33447243", "kind": "science-record", "revision": 4, "content_hash": "sha256:6692be832d929608d859d6e75735d732c004ce2208f8c38935bf6f28ef2a1abc", "created_at": "2026-11-01T15:41:22Z", "updated_at": "2026-11-01T21:24:31Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment.", "doi": "10.3389/fphar.2020.594087", "pmid": "33447243", "authors": ["Irmela Mantel", "Angelica Borgo", "Jacopo Guidotti", "Edwige Forestier", "Olga Kirsch", "Yasmine Derradji", "Patrice Waridel", "Frédéric Burdet", "Florence Mehl", "Claude Schweizer", "Raphaël Roduit"], "journal": "Frontiers in pharmacology", "year": 2020, "abstract": "The standard treatment for neovascular age-related macular degeneration (nAMD) consists of intravitreal anti-vascular endothelial growth factors (VEGF). However, for some patients, even maximal anti-VEGF treatment does not entirely suppress exudative activity. The goal of this study was to identify molecular biomarkers in nAMD with incomplete response to anti-VEGF treatment. Aqueous humor (AH) samples were collected from three groups of patients: 17 patients with nAMD responding incompletely to anti-VEGF (18 eyes), 17 patients affected by nAMD with normal treatment response (21 eyes), and 16 control patients without any retinopathy (16 eyes). Proteomic and multiplex analyses were performed on these samples. Proteomic analyses showed that nAMD patients with incomplete anti-VEGF response displayed an increased inflammatory response, complement activation, cytolysis, protein-lipid complex, and vasculature development pathways. Multiplex analyses revealed a significant increase of soluble vascular cell adhesion molecule-1 (sVCAM-1) [ p = 0.001], interleukin-6 (IL-6) [ p = 0.009], bioactive interleukin-12 (IL-12p40) [ p = 0.03], plasminogen activator inhibitor type 1 (PAI-1) [ p = 0.004], and hepatocyte growth factor (HGF) [ p = 0.004] levels in incomplete responders in comparison to normal responders. Interestingly, the same biomarkers showed a high intercorrelation with r2 values between 0.58 and 0.94. In addition, we confirmed by AlphaLISA the increase of sVCAM-1 [ p < 0.0001] and IL-6 [ p = 0.043] in the incomplete responder group. Incomplete responders in nAMD are associated with activated angiogenic and inflammatory pathways. The residual exudative activity of nAMD despite maximal anti-VEGF treatment may be related to both angiogenic and inflammatory responses requiring specific adjuvant therapy. Data are available via ProteomeXchange with identifier PXD02247.", "claims": [{"id": "claim-method", "statement": "For analysis of the proteomics results, linear models (R function lm) adjusted for batches were used to identify differentially expressed proteins (p < 0.1) to compare group N and group R and to compare groups C/N and group R.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:33447243", "locator": "sections[11] \"Bio-Informatic Analyses\" paragraph 2", "quote": "For analysis of the proteomics results, linear models (R function lm) adjusted for batches were used to identify differentially expressed proteins (p < 0.1) to compare group N and group R and to compare groups C/N and group R."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD022471.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:33447243", "locator": "sections[20] \"Data Availability Statement\" paragraph 2", "quote": "The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD022471."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:33447243"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD022471"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD022471"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:33447243", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3389/fphar.2020.594087", "sha256": "sha256:7f3a2d31011392e61dd1ae22fe61a517e00f57a4fd14f8a83937ec672ae2305f", "bytes": 57358, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3389/fphar.2020.594087", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC7802772", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD022471", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD022471", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD022471", "version": null, "note": "The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD022471.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD022471.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": "Molecular biomarkers of neovascular age-related macular degeneration with incomplete response to anti-vascular endothelial growth factor treatment", "resolution_checked_at": "2026-10-31T18:35:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:33447243:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:4c72cb3d2ee6e9e926bc3ef335e5dfa9eb0eba95c8efbbdc9fe98a6203823d3a", "bytes": 2618, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[1]#T2", "version": null, "note": "Multiplex analysis of AH from nAMD patients with normal response (N), incomplete response (R) patients, and controls (C).", "structure": {"pmcid": "PMC7802772", "section_index": 8, "section_title": "Multiplex Analysis", "row_count": 25, "column_count": 7}, "table": {"label": "TABLE 2", "caption": "Multiplex analysis of AH from nAMD patients with normal response (N), incomplete response (R) patients, and controls (C).", "rows": [["", "Control C (n)", "nAMD N (n)", "rAMD R (n)", "p values"], ["C vs. N", "C vs. R", "R vs. N"], ["VEGFR-1", "100 ± 15.58 (9)", "4,569 ± 1,228 (13)", "4,738 ± 1,216 (12)", "*0.024", "*0.024", "0.910"], ["VEGFR-2", "100 ± 5.85 (9)", "172.1 ± 18.46 (13)", "220.8 ± 28.66 (12)", "0.055", "*0.002", "0.110"], ["VEGF-A", "100 ± 9.53 (14)", "714 ± 142.8 (19)", "712.4 ± 125.6 (18)", "**0.003", "**0.003", "0.992"], ["EGF", "100 ± 2.14 (10)", "105 ± 3.26 (10)", "110.5 ± 1.71 (10)", "0.242", "*0.016", "0.242"], ["Eotaxin", "100 ± 12.57 (13)", "165 ± 23.5 (19)", "238.8 ± 41.1 (18)", "0.154", "*0.011", "0.151"], ["HGF", "100 ± 10.03 (14)", "129.4 ± 10.82 (19)", "232 ± 35.43 (18)", "0.388", "**0.001", "**0.004"], ["IL-12p40", "100 ± 7.40 (14)", "155.9 ± 14.15 (19)", "210 ± 20.47 (18)", "*0.031", "#0.0001", "*0.031"], ["sVCAM-1", "100 ± 8.93 (14)", "122.8 ± 12.63 (19)", "242.7 ± 35.69 (18)", "0.511", "#0.0005", "**0.001"], ["IL-6", "100 ± 25.70 (6)", "86.12 ± 64.25 (7)", "10,546 ± 7,320 (10)", "*0.042", "0.11", "**0.009"], ["IP-10", "100 ± 16.91 (14)", "235.5 ± 42.06 (19)", "280.2 ± 62.2 (18)", "0.107", "*0.038", "0.490"], ["MCP-1", "100 ± 6.46 (14)", "137.8 ± 11.16 (19)", "154.3 ± 11.35 (18)", "*0.032", "**0.002", "0.253"], ["MMP-9", "100 ± 18.31 (13)", "233.3 ± 42.79 (19)", "325.4 ± 64.23 (18)", "0.144", "*0.011", "0.174"], ["Adiponectin", "100 ± 33.65 (4)", "131.7 ± 32.36 (9)", "173.2 ± 60.66 (8)", "0.762", "0.741", "0.762"], ["Eotaxin-3", "100 ± 18.98 (5)", "145.9 ± 27.1 (9)", "120.3 ± 19.7 (10)", "0.781", "0.857", "0.781"], ["Ghrelin", "100 ± 5.83 (4)", "105.3 ± 5.74 (9)", "103 ± 8.74 (8)", "0.960", "0.960", "0.960"], ["IL-3", "100 ± 25.06 (5)", "122.7 ± 36.17 (4)", "110.5 ± 23.78 (5)", "0.946", "0.946", "0.928"], ["IL-7", "100 ± 18.25 (8)", "290.5 ± 44.59 (12)", "360.1 ± 40.22 (11)", "**0.006", "#0.0005", "0.203"], ["MIF", "100 ± 17.19 (4)", "138.9 ± 20.84 (9)", "133.5 ± 20.95 (8)", "0.619", "0.619", "0.848"], ["NGAL", "100 ± 19.1 (9)", "120.1 ± 10.53 (13)", "135.4 ± 13.54 (12)", "0.451", "0.187", "0.451"], ["PaI-1", "100 ± 8.5 (12)", "179.9 ± 18.39 (13)", "425.7 ± 89.64 (13)", "0.304", "#0.0005", "**0.005"], ["Gro-alpha-KC", "100 ± 8.27 (14)", "94.71 ± 5.60 (19)", "162.7 ± 42.79 (17)", "0.887", "0.199", "0.1669"], ["IL-1RA", "100 ± 32.02 (12)", "70.77 ± 14.78 (16)", "149 ± 61.91 (14)", "0.652", "0.652", "0.4121"], ["IL-13", "100 ± 0.90 (10)", "96.14 ± 3.46 (10)", "97.66 ± 2.16 (10)", "0.608", "0.749", "0.749"]], "row_count": 25, "column_count": 7, "numeric_cells": 152, "header_rows": 2, "locator": "section[17]/table-wrap[1]#T2"}}, {"id": "asset:table:pmid:33447243:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:9433448ec5580580b89013d72a94685d735ef3a7ba74f99dc7c6d5127b033258", "bytes": 1735, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[13]/table-wrap[1]#T1", "version": null, "note": "Demographic, phenotypic and treatment characteristics of each group based on the type of molecular analysis.", "structure": {"pmcid": "PMC7802772", "section_index": 13, "section_title": "Clinical Characteristics", "row_count": 25, "column_count": 4}, "table": {"label": "TABLE 1", "caption": "Demographic, phenotypic and treatment characteristics of each group based on the type of molecular analysis.", "rows": [["", "rAMD (R)", "nAMD (N)", "Control (C)"], ["N patients", "17", "17", "16"], ["Mean age (SD)", "81.6 (±6.5)", "81.6 (±5.9)", "70.44 ± 2.47"], ["Females (%)", "13 (76.5%)", "13 (76.5%)", "8/8"], ["N eyes", "18", "19", "16"], ["Right eyes/left eyes", "14/4", "7/13", "10/6"], ["Neovascularization type: 1/2/3", "15/2/1", "16/3/1", "—"], ["Presence of reticular pseudodrusen (%)", "5 (28%)", "7 (35%)", "—"], ["Presence of fibrosis (%)", "3 (17%)", "4 (20%)", "—"], ["Presence of cRORA", "4 (22%)", "10 (50%)", "—"], ["Presence of iRORA", "6 (33%)", "14 (70%)", "—"], ["Recurrences including IRF (%)", "9 (50%)", "17 (85%)", "—"], ["Recurrences including SRF (%)", "12 (67%)", "8 (40%)", "—"], ["Mean CRT in micrometers (SD)", "323 (±83)", "286 (±76)", "—"], ["Mean subfoveal choroidal thickness in micrometers (SD)", "150 (±121)", "166 (±64)", "—"], ["Treatment duration in months ± SD", "69.7 ± 35.1", "55.4 ± 36.2", "—"], ["Number of injections received ± SD", "59.6 ± 29.9", "36.4 ± 26.7", "—"], ["Weeks from preceding injection ± SEM", "5.89 ± 0.94", "3.97 ± 0.29", "—"], ["Anti-VEGF agent used (ranib./Aflib.)", "8/10", "8/12", "—"], ["Number of switches performed", "", "", ""], ["0", "3", "13", "—"], ["1", "9", "7", "—"], ["2", "6", "0", "—"], ["Mean visual acuity at treatment initiation in ETDRS letters ± SD", "61.7 ± 12.5", "63.1 ± 16.1", "—"], ["Mean visual acuity change from baseline in ETDRS letters ± SD", "7.9 ± 12.5", "Before cataract surgery −9.4 ± 12.9 after cataract surgery 12.8 ± 11.8", "—"]], "row_count": 25, "column_count": 4, "numeric_cells": 55, "header_rows": 1, "locator": "section[13]/table-wrap[1]#T1"}}, {"id": "asset:table:pmid:33447243:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:4c72cb3d2ee6e9e926bc3ef335e5dfa9eb0eba95c8efbbdc9fe98a6203823d3a", "bytes": 2618, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[1]#T2", "version": null, "note": "Multiplex analysis of AH from nAMD patients with normal response (N), incomplete response (R) patients, and controls (C).", "structure": {"pmcid": "PMC7802772", "section_index": 17, "section_title": "Multiplex Analysis", "row_count": 25, "column_count": 7}, "table": {"label": "TABLE 2", "caption": "Multiplex analysis of AH from nAMD patients with normal response (N), incomplete response (R) patients, and controls (C).", "rows": [["", "Control C (n)", "nAMD N (n)", "rAMD R (n)", "p values"], ["C vs. N", "C vs. R", "R vs. N"], ["VEGFR-1", "100 ± 15.58 (9)", "4,569 ± 1,228 (13)", "4,738 ± 1,216 (12)", "*0.024", "*0.024", "0.910"], ["VEGFR-2", "100 ± 5.85 (9)", "172.1 ± 18.46 (13)", "220.8 ± 28.66 (12)", "0.055", "*0.002", "0.110"], ["VEGF-A", "100 ± 9.53 (14)", "714 ± 142.8 (19)", "712.4 ± 125.6 (18)", "**0.003", "**0.003", "0.992"], ["EGF", "100 ± 2.14 (10)", "105 ± 3.26 (10)", "110.5 ± 1.71 (10)", "0.242", "*0.016", "0.242"], ["Eotaxin", "100 ± 12.57 (13)", "165 ± 23.5 (19)", "238.8 ± 41.1 (18)", "0.154", "*0.011", "0.151"], ["HGF", "100 ± 10.03 (14)", "129.4 ± 10.82 (19)", "232 ± 35.43 (18)", "0.388", "**0.001", "**0.004"], ["IL-12p40", "100 ± 7.40 (14)", "155.9 ± 14.15 (19)", "210 ± 20.47 (18)", "*0.031", "#0.0001", "*0.031"], ["sVCAM-1", "100 ± 8.93 (14)", "122.8 ± 12.63 (19)", "242.7 ± 35.69 (18)", "0.511", "#0.0005", "**0.001"], ["IL-6", "100 ± 25.70 (6)", "86.12 ± 64.25 (7)", "10,546 ± 7,320 (10)", "*0.042", "0.11", "**0.009"], ["IP-10", "100 ± 16.91 (14)", "235.5 ± 42.06 (19)", "280.2 ± 62.2 (18)", "0.107", "*0.038", "0.490"], ["MCP-1", "100 ± 6.46 (14)", "137.8 ± 11.16 (19)", "154.3 ± 11.35 (18)", "*0.032", "**0.002", "0.253"], ["MMP-9", "100 ± 18.31 (13)", "233.3 ± 42.79 (19)", "325.4 ± 64.23 (18)", "0.144", "*0.011", "0.174"], ["Adiponectin", "100 ± 33.65 (4)", "131.7 ± 32.36 (9)", "173.2 ± 60.66 (8)", "0.762", "0.741", "0.762"], ["Eotaxin-3", "100 ± 18.98 (5)", "145.9 ± 27.1 (9)", "120.3 ± 19.7 (10)", "0.781", "0.857", "0.781"], ["Ghrelin", "100 ± 5.83 (4)", "105.3 ± 5.74 (9)", "103 ± 8.74 (8)", "0.960", "0.960", "0.960"], ["IL-3", "100 ± 25.06 (5)", "122.7 ± 36.17 (4)", "110.5 ± 23.78 (5)", "0.946", "0.946", "0.928"], ["IL-7", "100 ± 18.25 (8)", "290.5 ± 44.59 (12)", "360.1 ± 40.22 (11)", "**0.006", "#0.0005", "0.203"], ["MIF", "100 ± 17.19 (4)", "138.9 ± 20.84 (9)", "133.5 ± 20.95 (8)", "0.619", "0.619", "0.848"], ["NGAL", "100 ± 19.1 (9)", "120.1 ± 10.53 (13)", "135.4 ± 13.54 (12)", "0.451", "0.187", "0.451"], ["PaI-1", "100 ± 8.5 (12)", "179.9 ± 18.39 (13)", "425.7 ± 89.64 (13)", "0.304", "#0.0005", "**0.005"], ["Gro-alpha-KC", "100 ± 8.27 (14)", "94.71 ± 5.60 (19)", "162.7 ± 42.79 (17)", "0.887", "0.199", "0.1669"], ["IL-1RA", "100 ± 32.02 (12)", "70.77 ± 14.78 (16)", "149 ± 61.91 (14)", "0.652", "0.652", "0.4121"], ["IL-13", "100 ± 0.90 (10)", "96.14 ± 3.46 (10)", "97.66 ± 2.16 (10)", "0.608", "0.749", "0.749"]], "row_count": 25, "column_count": 7, "numeric_cells": 152, "header_rows": 2, "locator": "section[17]/table-wrap[1]#T2"}}, {"id": "asset:table:pmid:33447243:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:60d7eb0ee8ab4d0c44bf2396ba1dbe52b111c6c2797865d8207d7d31d2956d09", "bytes": 1783, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[18]/table-wrap[1]#T3", "version": null, "note": "Clinical-Molecular Association Analysis: The five relevant molecules, associated with incomplete anti-VEGF response, were explored for potential associations with clinical parameters, in all neovascular age-related macular degeneration (nAMD) eyes included. Correlation analysis was performed for continuous variable, and Anova test for categorical variables.", "structure": {"pmcid": "PMC7802772", "section_index": 18, "section_title": "Exploratory Clinical-Molecular Correlation", "row_count": 16, "column_count": 13}, "table": {"label": "TABLE 3", "caption": "Clinical-Molecular Association Analysis: The five relevant molecules, associated with incomplete anti-VEGF response, were explored for potential associations with clinical parameters, in all neovascular age-related macular degeneration (nAMD) eyes included. Correlation analysis was performed for continuous variable, and Anova test for categorical variables.", "rows": [["", "sVCAM-1", "IL-12p40", "IL-6", "PAI-1", "HGF", "VEGF-A"], ["Continuous variables", "r2", "p", "r2", "p", "r2", "p", "r2", "p", "r2", "p", "r2", "p"], ["Age", "0.20", "0.22", "0.32", "0.05", "0.17", "0.29", "0.24", "0.13", "0.38", "0.01", "0.07", "0.67"], ["N anti-VEGF injections", "0.26", "0.10", "0.30", "0.06", "0.26", "0.11", "0.13", "0.42", "0.26", "0.10", "0.13", "0.42"], ["N months of treatment", "0.14", "0.40", "0.21", "0.19", "0.25", "0.10", "0.08", "0.60", "0.15", "0.35", "0.09", "0.60"], ["VA change from baseline", "0.18", "0.25", "0.01", "0.93", "−0.35", "0.03", "0.16", "0.32", "0.18", "0.27", "−0.11", "0.47"], ["Central retinal thickness", "0.19", "0.24", "0.29", "0.07", "0.04", "0.80", "0.26", "0.12", "0.18", "0.26", "0.04", "0.82"], ["Subfoveal choroidal thickness", "−0.40", "0.01", "−0.46", "0.003", "−0.27", "0.10", "−0.26", "0.10", "−0.44", "0.005", "−0.14", "0.38"], ["Categorical variables", "p", "p", "p", "p", "p", "p"], ["Reticular pseudodrusen", "0.38", "0.69", "0.36", "0.56", "0.86", "0.58"], ["Intraretinal fluid", "0.74", "0.87", "0.22", "0.41", "0.8", "0.55"], ["Subretinal fluid", "0.73", "0.4", "0.42", "0.99", "0.93", "0.69"], ["cRORA", "0.83", "0.7", "0.36", "0.36", "0.7", "0.51"], ["iRORA", "0.97", "0.61", "0.42", "0.89", "0.71", "0.65"], ["CNV type", "0.1", "0.62", "0.83", "0.005", "0.36", "0.38"], ["Fibrosis", "0.95", "0.92", "0.66", "0.5", "0.99", "0.5"]], "row_count": 16, "column_count": 13, "numeric_cells": 118, "header_rows": 2, "locator": "section[18]/table-wrap[1]#T3"}}], "gaps": ["asset:data:geo:PXD022471 not downloaded", "asset:data:geo:PXD022471 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": null, "specific": null, "label": "Linear models adjusted for batches", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "For analysis of the proteomics results, linear models (R function lm) adjusted for batches were used to identify differentially expressed proteins (p < 0.1) to compare group N and group R and to compare groups C/N and group R."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "method", "blocked_on": "method:not_determinable", "axes": {"method": {"tier": "R4", "expressible": false, "required_operations": [], "missing_operations": [], "basis": "The reader quoted the method the paper names (Linear models adjusted for batches), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["PXD022471"], "resolved_accessions": ["PXD022471"], "statements": ["The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD022471."], "basis": "The paper names PXD022471 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:33447243", "data:geo:PXD022471", "asset:table:pmid:33447243:1", "asset:table:pmid:33447243:2", "asset:table:pmid:33447243:3", "asset:table:pmid:33447243:4"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD022471"]}, "gaps": ["method:not_determinable"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:26:11Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 44123, "completion_tokens": 1449, "cached_tokens": 14856}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:33447243", "type": "paper", "label": "pmid:33447243"}, {"id": "source:pmid:33447243", "type": "manuscript", "label": "PMID 33447243 full text"}, {"id": "data:geo:PXD022471", "type": "dataset", "label": "GEO PXD022471"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:33447243", "type": "paper", "label": "pmid:33447243"}, {"id": "source:pmid:33447243", "type": "manuscript", "label": "PMID 33447243 full text"}, {"id": "data:geo:PXD022471", "type": "dataset", "label": "GEO PXD022471"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-33447243", "type": "extraction", "used": ["source:pmid:33447243"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD022471", "type": "accession_resolution", "used": ["data:geo:PXD022471"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:33447243", "parent_hash": "sha256:db3b0101ffe8f094980180f8efab593032625d771e8696f8e225ea82fc6a00ae", "fork_of": null, "generation": 3}, "gaps": ["asset:data:geo:PXD022471 licence not read", "asset:data:geo:PXD022471 not downloaded", "execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique"]}